Pseudoephedrine
Pseudoephedrine is a sympathomimetic decongestant used for the temporary relief of nasal and sinus congestion associated with the common cold, allergies, and sinusitis. It works by stimulating alpha-adrenergic receptors, causing blood vessels in the nasal passages to constrict and reducing swelling and congestion. It is available in immediate- and extended-release oral tablets, capsules, and liquid formulations, and is often combined with antihistamines or pain relievers. Common side effects include restlessness, insomnia, dry mouth, headache, and increased heart rate. Important risks include elevated blood pressure, palpitations, and, rarely, serious cardiovascular or neurological complications. It should be used cautiously in people with hypertension, heart disease, hyperthyroidism, or glaucoma, and should not be combined with monoamine oxidase inhibitors or used without medical advice when taking other stimulant medicines.
Pseudoephedrine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Pseudoephedrine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Pseudoephedrine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Pseudoephedrine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
